Evaluation of the Effect of Ethyl Acrylate-Methyl Methacrylate Copolymer in Racecadotril Dispersible Tablet.

IF 1.8 Q3 PHARMACOLOGY & PHARMACY
Onur Pınarbaşlı, Burcu Bulut, Gülistan Pelin Gurbetoğlu, Nurdan Atılgan, Nagehan Sarraçoğlu, Asuman Aybey
{"title":"Evaluation of the Effect of Ethyl Acrylate-Methyl Methacrylate Copolymer in Racecadotril Dispersible Tablet.","authors":"Onur Pınarbaşlı,&nbsp;Burcu Bulut,&nbsp;Gülistan Pelin Gurbetoğlu,&nbsp;Nurdan Atılgan,&nbsp;Nagehan Sarraçoğlu,&nbsp;Asuman Aybey","doi":"10.4274/tjps.galenos.2021.50432","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Racecadotril is an anti-diarrheal drug that has the indication to reduce the secretion of water and electrolytes into the intestine. It has an unpleasant taste, when administered orally. The presenting study developed a pharmaceutical racecadotril dispersible tablet, which masked the unpleasent taste using wet granulation method. For this reason, the effect of the number of ethylacrylate-methylmethacrylate copolymers (Eudragit<sup>®</sup> NE 30D) in taste masking and <i>in vitro</i> dissolution of the finished product was investigated.</p><p><strong>Materials and methods: </strong>Taste-masked racecadotril granules were prepared using Eudragit<sup>®</sup> NE 30D and the ratio between the amounts of racecadotril and Eudragit<sup>®</sup> NE 30D involved in the formulation was optimized. The products obtained in the dispersible tablet dosage form were evaluated in terms of taste and <i>in vitro</i> dissolution studies. <i>In vitro</i> dissolution profiles of the products obtained in this study were compared with reference product Tiorfan<sup>®</sup> granules for oral suspension manufactured by Bioprojet Pharma (Paris, France). A method of apparatus II (paddle), 900 mL, pH 4.5 acetate buffer + 1% sodium dodecyl sulfate (SDS) and 100 rpm at 37.0 ± 0.5°C was adopted.</p><p><strong>Results: </strong>Results of the studies have shown that the formulation should have Eudragit<sup>®</sup> NE 30D higher than 1% by weight of racecadotril to satisfy the taste-masking ability and the formulation should have Eudragit<sup>®</sup> NE 30D equal or lower than 10% by weight of racecadotril to have better release characteristic to be compatible with reference product.</p><p><strong>Conclusion: </strong>Our results demonstrated that a chemically long-term stable racecadotril dispersible tablet product, whose taste is efficiently masked using wet granulation method with an acceptable release profile was obtained with Eudragit<sup>®</sup> NE 30D ratio higher than 1% and equal or lower than 10% by weight of racecadotril. The developed formulation can increase patient compliance.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"383-390"},"PeriodicalIF":1.8000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438762/pdf/TJPS-19-383.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/tjps.galenos.2021.50432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives: Racecadotril is an anti-diarrheal drug that has the indication to reduce the secretion of water and electrolytes into the intestine. It has an unpleasant taste, when administered orally. The presenting study developed a pharmaceutical racecadotril dispersible tablet, which masked the unpleasent taste using wet granulation method. For this reason, the effect of the number of ethylacrylate-methylmethacrylate copolymers (Eudragit® NE 30D) in taste masking and in vitro dissolution of the finished product was investigated.

Materials and methods: Taste-masked racecadotril granules were prepared using Eudragit® NE 30D and the ratio between the amounts of racecadotril and Eudragit® NE 30D involved in the formulation was optimized. The products obtained in the dispersible tablet dosage form were evaluated in terms of taste and in vitro dissolution studies. In vitro dissolution profiles of the products obtained in this study were compared with reference product Tiorfan® granules for oral suspension manufactured by Bioprojet Pharma (Paris, France). A method of apparatus II (paddle), 900 mL, pH 4.5 acetate buffer + 1% sodium dodecyl sulfate (SDS) and 100 rpm at 37.0 ± 0.5°C was adopted.

Results: Results of the studies have shown that the formulation should have Eudragit® NE 30D higher than 1% by weight of racecadotril to satisfy the taste-masking ability and the formulation should have Eudragit® NE 30D equal or lower than 10% by weight of racecadotril to have better release characteristic to be compatible with reference product.

Conclusion: Our results demonstrated that a chemically long-term stable racecadotril dispersible tablet product, whose taste is efficiently masked using wet granulation method with an acceptable release profile was obtained with Eudragit® NE 30D ratio higher than 1% and equal or lower than 10% by weight of racecadotril. The developed formulation can increase patient compliance.

丙烯酸乙酯-甲基丙烯酸甲酯共聚物在消旋卡多曲分散片中作用的评价。
目的:消旋卡多曲是一种抗腹泻药物,具有减少肠内水和电解质分泌的适应症。口服时,它有一种难闻的味道。本研究研制了一种消旋卡多曲分散片,用湿造粒法掩盖了消旋卡多曲的涩味。为此,研究了丙烯酸乙酯-甲基丙烯酸甲酯共聚物(Eudragit®NE 30D)的数量对掩味和成品体外溶出度的影响。材料与方法:以优德拉吉特®NE 30D为原料制备消味消旋卡多曲颗粒,优化消旋卡多曲与优德拉吉特®NE 30D的用量比例。以分散片剂型获得的产品进行了口感评价和体外溶出度研究。将本研究获得的产品的体外溶出度与Bioprojet Pharma (Paris, France)生产的参比产品Tiorfan®口服混悬剂颗粒进行比较。采用仪器II(桨),900 mL, pH为4.5的醋酸缓冲液+ 1%十二烷基硫酸钠(SDS), 100 rpm, 37.0±0.5°C。结果:研究结果表明,Eudragit®NE 30D含量应大于消旋卡多曲重量的1%,以满足消旋卡多曲的掩味能力;Eudragit®NE 30D含量应等于或低于消旋卡多曲重量的10%,以获得较好的释放特性,与参比品配伍。结论:当Eudragit®NE 30D与消旋卡多曲的质量比大于1%,等于或小于10%时,可获得化学长期稳定的消旋卡多曲分散片产品,湿造粒法能有效掩盖消旋卡多曲的口感,且释放曲线可接受。开发的配方可以提高患者的依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
5.90%
发文量
79
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信